Product
CVI-VZV-001
1 clinical trial
2 indications
Indication
Vaccine-Preventable DiseasesIndication
Herpes ZosterClinical trial
A Multicenter, Active-controlled, Open-label Phase I Study to Assess Safety and Tolerability and to Explore Immunogenicity of CVI-VZV-001 Vaccine in Healthy Adults Aged 50 to 64 YearsStatus: Recruiting, Estimated PCD: 2025-03-21